Cargando…
IL‐17A‐producing CD30(+) Vδ1 T cells drive inflammation‐induced cancer progression
Although it has been suspected that inflammation is associated with increased tumor metastasis, the exact type of immune response required to initiate cancer progression and metastasis remains unknown. In this study, by using an in vivo tumor progression model in which low tumorigenic cancer cells a...
Autores principales: | Kimura, Yoshitaka, Nagai, Nao, Tsunekawa, Naoki, Sato‐Matsushita, Marimo, Yoshimoto, Takayuki, Cua, Daniel J., Iwakura, Yoichiro, Yagita, Hideo, Okada, Futoshi, Tahara, Hideaki, Saiki, Ikuo, Irimura, Tatsuro, Hayakawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021032/ https://www.ncbi.nlm.nih.gov/pubmed/27384869 http://dx.doi.org/10.1111/cas.13005 |
Ejemplares similares
-
Mammary tissue microenvironment determines T cell-dependent breast cancer-associated inflammation
por: Takahashi, Kei, et al.
Publicado: (2015) -
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
por: Sato-Matsushita, Marimo, et al.
Publicado: (2015) -
Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer
por: REFAAT, ALAA, et al.
Publicado: (2013) -
Milk fat globule epidermal growth factor–8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms
por: Jinushi, Masahisa, et al.
Publicado: (2009) -
Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402
por: Baba, Toshiyuki, et al.
Publicado: (2010)